BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36858679)

  • 1. Systemic Delivery of Extracellular Vesicles Attenuates Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction.
    Zhang R; Mesquita T; Cho JH; Li C; Sanchez L; Holm K; Akhmerov A; Liu W; Li Y; Ibrahim AG; Cingolani E
    JACC Clin Electrophysiol; 2023 Feb; 9(2):147-158. PubMed ID: 36858679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction.
    Mesquita TRR; Zhang R; de Couto G; Valle J; Sanchez L; Rogers RG; Holm K; Liu W; Marbán E; Cingolani E
    Heart Rhythm; 2020 Jun; 17(6):1025-1033. PubMed ID: 32068183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats.
    Yang H; Zhu J; Fu H; Shuai W
    Heart Lung Circ; 2024 Jan; 33(1):65-77. PubMed ID: 38040503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure and Preserved Ejection Fraction.
    Zylla MM; Leiner J; Rahm AK; Hoffmann T; Lugenbiel P; Schweizer P; Scholz E; Mereles D; Kronsteiner D; Kieser M; Katus HA; Frey N; Thomas D
    Circ Heart Fail; 2022 Sep; 15(9):e009281. PubMed ID: 36126143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
    de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
    Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Symptomatic Atrial Fibrillation.
    Ariyaratnam JP; Elliott AD; Mishima RS; Kadhim K; McNamee O; Kuklik P; Emami M; Malik V; Fitzgerald JL; Gallagher C; Lau DH; Sanders P
    JACC Heart Fail; 2023 Nov; 11(11):1626-1638. PubMed ID: 37676212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Heart Failure With Preserved Ejection Fraction in Patients Undergoing Atrial Fibrillation Ablation Based on Resting and Post-Tachycardia Pacing Left Atrial Pressure.
    Chacko P; Bhuta S; Meenakshisundaram C; Moustafa A; Davis A; Gupta R
    Am J Cardiol; 2023 Oct; 205():445-450. PubMed ID: 37666016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified P-wave duration predicts new-onset atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Müller-Edenborn B; Minners J; Kocher S; Chen J; Zeh W; Lehrmann H; Allgeier J; Neumann FJ; Arentz T; Jadidi A
    Clin Res Cardiol; 2020 Aug; 109(8):978-987. PubMed ID: 31863175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.
    Cho JH; Kilfoil PJ; Zhang R; Solymani RE; Bresee C; Kang EM; Luther K; Rogers RG; de Couto G; Goldhaber JI; Marbán E; Cingolani E
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis.
    Rattka M; Kühberger A; Pott A; Stephan T; Weinmann K; Baumhardt M; Aktolga D; Teumer Y; Bothner C; Scharnbeck D; Rottbauer W; Dahme T
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2357-2367. PubMed ID: 34379370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction.
    Weerts J; Barandiarán Aizpurua A; Henkens MTHM; Lyon A; van Mourik MJW; van Gemert MRAA; Raafs A; Sanders-van Wijk S; Bayés-Genís A; Heymans SRB; Crijns HJGM; Brunner-La Rocca HP; Lumens J; van Empel VPM; Knackstedt C
    Eur Heart J Cardiovasc Imaging; 2021 Dec; 23(1):74-84. PubMed ID: 34718457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction.
    Ikoma T; Obokata M; Okada K; Harada T; Sorimachi H; Yoshida K; Kato T; Kurosawa K; Kurabayashi M; Murakami M
    J Card Fail; 2021 May; 27(5):577-584. PubMed ID: 33385523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.